<DOC>
	<DOC>NCT01164397</DOC>
	<brief_summary>The aim of this study is to evaluate the effectiveness of Rosuvastatin versus Ezetimibe/Simvastatin in dyslipidemic patients treated for at least 8 weeks.</brief_summary>
	<brief_title>Efficiency of Rosuvastatin Versus the Fixed Combination of Ezetimibe/Simvastatin in Outpatients</brief_title>
	<detailed_description />
	<mesh_term>Dyslipidemias</mesh_term>
	<mesh_term>Ezetimibe, Simvastatin Drug Combination</mesh_term>
	<mesh_term>Ezetimibe</mesh_term>
	<mesh_term>Simvastatin</mesh_term>
	<mesh_term>Rosuvastatin Calcium</mesh_term>
	<criteria>Dislipidemic population treated with rosuvastatin or ezetimibe/simvastatin for at least for 8 weeks Who have completed at least 80% of the treatment To have determinations at least of CT, TG CLDL and CHDL before starting treatment and after 8 weeks of taking the medicine Initiating different therapy lipid lowering to Rosuvastatin or Ezetimibe/Simvastatin</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2012</verification_date>
	<keyword>Hypercholesterolemia</keyword>
	<keyword>Statins</keyword>
</DOC>